About Dr Reddy’s Laboratories
Dr Reddy’s Laboratories Q3 Fy2024 Key Points and Summary:
Shareholding Pattern Dr Reddy’s Laboratories
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
Promoters + | 26.69% | 26.69% | 26.69% | 26.66% | 26.65% |
FIIs + | 27.29% | 27.25% | 26.99% | 28.19% | 28.62% |
DIIs + | 23.38% | 23.05% | 21.99% | 21.04% | 18.65% |
Public + | 22.36% | 22.78% | 24.11% | 23.93% | 25.89% |
Others + | 0.25% | 0.22% | 0.21% | 0.18% | 0.18% |
No. of Shareholders | 2,46,788 | 2,32,715 | 2,46,769 | 2,43,445 | 2,57,794 |
Dr Reddy’s Laboratories Share Price Target 2024 To 2030
Dr Reddy’s Laboratories Share Price Target 2024
Dr Reddys Laboratories Share Price Target 2025
When | Maximum Price | Minimum Price |
January 2025 | 6,954.96 | 5,349.97 |
February 2025 | 6,968.90 | 5,360.69 |
March 2025 | 7,115.24 | 5,473.26 |
April 2025 | 6,975.73 | 5,365.95 |
May 2025 | 6,772.55 | 5,209.66 |
June 2025 | 7,077.32 | 5,444.09 |
July 2025 | 6,938.55 | 5,337.34 |
August 2025 | 7,153.14 | 5,502.42 |
September 2025 | 7,238.98 | 5,568.44 |
October 2025 | 7,427.19 | 5,713.22 |
November 2025 | 7,612.87 | 5,856.05 |
December 2025 | 7,955.45 | 6,119.58 |
Dr Reddys Laboratories Share Price Target 2026 To 2030
Dr Reddys Laboratories ‘s Financial Condition (Last 5 Years)
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
Sales + | 15,448 | 17,517 | 19,048 | 21,545 | 24,670 | 26,766 |
Expenses + | 12,270 | 15,040 | 15,173 | 17,778 | 18,200 | 19,223 |
Operating Profit | 3,178 | 2,477 | 3,874 | 3,768 | 6,470 | 7,543 |
OPM % | 21% | 14% | 20% | 17% | 26% | 28% |
Other Income + | 381 | 670 | 335 | 555 | 971 | 708 |
Interest | 89 | 98 | 97 | 96 | 143 | 150 |
Depreciation | 1,135 | 1,163 | 1,229 | 1,165 | 1,250 | 1,368 |
Profit before tax | 2,336 | 1,886 | 2,884 | 3,061 | 6,048 | 6,734 |
Tax % | 17% | -7% | 32% | 29% | 25% | |
Net Profit + | 1,950 | 2,026 | 1,952 | 2,182 | 4,507 | 5,091 |
EPS in Rs | 117.42 | 121.92 | 117.35 | 131.14 | 270.66 | 305.58 |
Dividend Payout % | 17% | 21% | 21% | 23% | 15% |
Leave a Reply